qli5 therapeutics Alternatives & Competitors
12 companies similar to qli5 therapeutics — Pioneering a breakthrough in proteasome inhibitors with unmatched selectivity an...
Companies similar to qli5 therapeutics
SiteOne Therapeutics Inc.
Pioneering safe and efficient treatments for pain with highly selective Naᵥ1.7 inhibitors.
San Francisco, United Sta...
AlloMek Therapeutics LLC
Dedicated to advancing cancer treatment through innovative MEK kinase inhibitors.
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
Bicycle Therapeutics
Precision-Guided Therapeutics
Cambridge, United Kingdom
Rival Readout
Competing with qli5 therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
ImCheck Therapeutics
Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic
Marseille, France
Saverna Therapeutics AG
Saverna Therapeutics aims to discover highly active, selective and cell-permeable molecule...
Allschwil, Switzerland
Forge Therapeutics
Harnessing the power of chemistry for innovative therapies targeting metalloproteins.
Certa Therapeutics
Developing innovative precision therapies for the treatment of inflammatory and fibrotic d...
Argonaut Therapeutics
Argonaut Therapeutics uses PRMT5 inhibitors and companion diagnostics for precision cancer...
Probmet Therapeutics
An oncology therapeutics company developing new targeted treatments for breast cancer brai...
Denmark
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
San Diego, United States
RiMO Therapeutics
Enhancing cancer treatment with innovative therapy to improve patient outcomes and reduce...
About qli5 therapeutics
Qli5 Therapeutics, founded in 2020, is forging new pathways in the Health and Wellness industry by developing an innovative class of proteasome inhibitors. Their approach uniquely combines high selectivity with non-covalent binding properties, setting them apart in the field. The startup's slogan, "Pioneering a breakth...
Development of next-generation proteasome inhibitors, Research collaboration with Max Planck Institute, Platform technology for unmet medical needs
Healthcare providers, Pharmaceutical companies, Biotech researchers, Cancer treatment centers, Patients with multiple myeloma, Patients with solid tumors
Proteasome Inhibitors, Selective Inhibition, Non-Covalent Binding, Therapeutics Development, Pharmaceutical Innovation, Drug Discovery, Targeted Therapy, Oncology Research, Molecular Medicine, Advanced Biomedicine
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around qli5 therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at qli5 therapeutics on 3 Apr 2026. The 12 companies listed here were last checked between 17 Jun 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
